Anteris Technologies to Present One-Year DurAVR THV Clinical Outcomes at PCR London Valves
Anteris Technologies announced that Dr. Rishi Puri of the Cleveland Clinic will present one-year clinical and hemodynamic outcomes for the DurAVR Transcatheter Heart Valve at the upcoming PCR London Valves conference.